{"gene":"FOXN4","run_date":"2026-06-09T23:54:44","timeline":{"discoveries":[{"year":2004,"finding":"Foxn4 is necessary and sufficient for commitment to the amacrine cell fate and is nonredundantly required for the genesis of horizontal cells in mouse retina. Targeted disruption largely eliminates amacrine neurons and completely abolishes horizontal cells, while overexpression strongly promotes amacrine cell fate. Foxn4 controls these fates by activating expression of retinogenic factors Math3, NeuroD1, and Prox1.","method":"Targeted gene disruption (knockout), overexpression in retinal progenitors, expression analysis of downstream targets","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function and gain-of-function with defined cellular phenotypes and downstream target activation, replicated across multiple studies","pmids":["15363391"],"is_preprint":false},{"year":2005,"finding":"Foxn4 cooperates with bHLH factor Mash1 to specify V2b interneuron identity from bipotential p2 progenitors in the spinal cord. Loss of Foxn4 eliminates Mash1 expression and V2b neurons with a fate-switch to V2a neurons. Overexpression of Foxn4 alone promotes V2a fate, but coexpression of Foxn4 and Mash1 together promotes the V2b fate while inhibiting V2a fate.","method":"Loss-of-function (Foxn4 knockout), overexpression in spinal neural progenitors, genetic epistasis with Mash1 knockout","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic manipulations (KO, OE, double mutant) with defined cellular phenotypes and pathway placement","pmids":["16020526"],"is_preprint":false},{"year":2007,"finding":"Foxn4 induces expression of Dll4 and Mash1 in p2 progenitors of the ventral spinal cord. Dll4 then signals through Notch1 to subdivide the p2 progenitor pool into V2a and V2b interneurons. Foxn4, Mash1, and activated Notch1 trigger the genetic cascade leading to V2b INs, while progenitors without active Notch1 generate V2a INs.","method":"Mouse and chick genetic experiments, loss-of-function and gain-of-function, epistasis analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — replicated in two model organisms with multiple genetic manipulations and pathway placement","pmids":["17728344"],"is_preprint":false},{"year":2008,"finding":"Zebrafish Foxn4 (encoded by slipjig) regulates atrioventricular canal formation by directly binding to a highly conserved tbx2 enhancer domain containing Foxn4- and T-box-binding sites, thereby regulating tbx2b expression in the AV canal.","method":"Genetic analysis in zebrafish, enhancer binding assay, identification of conserved Foxn4-binding sites in tbx2 enhancer","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct binding to enhancer demonstrated, zebrafish loss-of-function with specific cardiac phenotype, conserved binding sites functionally validated","pmids":["18347092"],"is_preprint":false},{"year":2012,"finding":"Foxn4 suppresses photoreceptor cell fates of early retinal progenitors by selectively activating Dll4-Notch signaling. Dll4 is directly activated by Foxn4 via phylogenetically conserved enhancers, and Dll4 mediates Foxn4 function by serving as a major Notch ligand to expand the progenitor pool and limit photoreceptor production.","method":"Bioinformatic, genetic, and biochemical approaches; conditional ablation; gene expression analysis; direct enhancer activation assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct enhancer activation, conditional genetics, multiple orthogonal methods in one study","pmids":["22323600"],"is_preprint":false},{"year":2013,"finding":"Foxn4 and Ascl1 (proneural bHLH factor) directly bind to a conserved Dll4 enhancer to activate Dll4 expression in V2 precursors, whereas Neurog proteins prevent this effect, resulting in asymmetric Dll4 activation. BMP/TGFβ signaling is activated in V2b precursors downstream of Dll4-Notch signaling, and this BMP/TGFβ signaling is necessary and sufficient for V2b fate specification.","method":"Direct enhancer binding assay, Cre-LoxP lineage tracing, gain-of-function, BMP/TGFβ pathway inhibition with antagonists and RNAi knockdown","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct enhancer binding demonstrated, multiple epistasis experiments, pathway inhibition with multiple methods","pmids":["24257627"],"is_preprint":false},{"year":2011,"finding":"Foxn4 is expressed in proximal airway epithelial cells during lung development. Targeted inactivation of Foxn4 causes dilated alveoli, thinned alveolar walls, and reduced septa in the distal lung, associated with decreased PDGFA signaling and reduced surfactant protein B (SFTPB) expression, suggesting a non-cell-autonomous role in alveologenesis.","method":"Targeted gene inactivation, histology, expression analysis of PDGFA and SFTPB","journal":"Developmental dynamics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO with defined phenotype and downstream pathway changes, single lab, no direct molecular mechanism for non-cell-autonomy established","pmids":["21438071"],"is_preprint":false},{"year":2011,"finding":"Foxn4 deletion reduces amacrine cell number without affecting RGC number, and Foxn4-null mice show a developmental delay in RGC projections to the superior colliculus and failure of RGC axons to penetrate retinorecipient layers. Foxn4 is not expressed by RGCs or in the superior colliculus, indicating this is an indirect (amacrine cell-mediated) effect on RGC axon patterning.","method":"Foxn4 knockout mouse analysis, immunohistochemistry for amacrine subtypes, retinal wave recording, axonal projection tracing","journal":"Molecular and cellular neurosciences","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — KO with defined cellular phenotype and non-cell-autonomous mechanism inferred, single lab, indirect mechanism not directly tested","pmids":["21334440"],"is_preprint":false},{"year":2011,"finding":"The region between amino acids 402 and 455 of Foxn4 protein (homologous to the activation domain of Foxn1) is required for Foxn4 transcriptional activity both in vitro (target promoter transcription assay) and in retina (regulation of target retinogenic factors). Deletion of this putative activation domain completely abolishes Foxn4 activity during retinogenesis.","method":"Domain deletion mutagenesis, gain-of-function in rat and chick retinal explants, target promoter transcription assay","journal":"Journal of molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — mutagenesis with in vitro and in vivo functional validation, single lab","pmids":["21701787"],"is_preprint":false},{"year":2013,"finding":"Meis1 transcription factor regulates Foxn4 expression during retinal progenitor differentiation by binding to a Meis1 binding motif within a conserved 129 bp cis-regulatory element (CR4.2) located ~26 kb upstream of the Foxn4 transcription start site. Knockdown of Meis1 abolishes CR4.2 regulatory activity and diminishes endogenous Foxn4 expression.","method":"Reporter assay with conserved cis-element, Meis1 binding motif deletion, Meis1 knockdown, expression analysis","journal":"Biology open","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — binding motif deletion and knockdown with reporter and endogenous expression validation, single lab","pmids":["24244849"],"is_preprint":false},{"year":2014,"finding":"FOXN4 exhibits substantial thymopoietic activity when substituted for FOXN1 in thymic epithelial cells of mice. The FOXN4-replaced thymus generates both T and B cells (bipotent lymphoid organ), linked to a functional imbalance between lymphopoietic cytokine IL7 and T cell specification factor DLL4, identifying the evolutionary mechanism underlying conversion of a general lymphopoietic organ to exclusive T cell generation.","method":"Knock-in replacement of FOXN1 with FOXN4 in mice, histological analysis, functional lymphocyte analysis, cytokine/ligand expression analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct in vivo replacement experiment with rigorous functional readouts, mechanistic pathway (IL7/DLL4 imbalance) identified","pmids":["25131198"],"is_preprint":false},{"year":2020,"finding":"Foxn4 functions as a temporal transcription factor (tTF) during retinogenesis, conferring retinal progenitor cells (RPCs) with competence to generate mid/late-early cell types (amacrine, horizontal, cone, rod cells) while suppressing generation of the immediate-early cell type (retinal ganglion cells). Foxn4 positively regulates its downstream tTF Casz1 while negatively regulating its upstream tTF Ikzf1. Retina-specific Foxn4 ablation also affects synaptogenesis and long-term retinal maintenance.","method":"Temporal cluster analysis, RNA-sequencing, retina-specific loss-of-function and gain-of-function, analysis of upstream/downstream tTF cascade","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal approaches (transcriptomics, KO, OE, epistasis within tTF cascade) in single study","pmids":["32071204"],"is_preprint":false},{"year":2019,"finding":"FOXN4 directly interacts with TP53 (p53 protein) in breast cancer cells, and this interaction leads to increased TP53 activity. Silencing FOXN4 reduces TP53 and increases expression of Dll4, Notch, and survivin.","method":"Co-immunoprecipitation (direct interaction with TP53), overexpression and knockdown in breast cancer cell lines, western blot","journal":"Gene","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP for interaction claim, single lab, limited mechanistic follow-up","pmids":["31430519"],"is_preprint":false},{"year":2020,"finding":"FOXN4 directly binds to the promoter of TP53 (P53) and activates P53 expression. Knockdown of P53 rescues the tumor-inhibitory effects of FOXN4 in breast cancer cells, placing FOXN4 upstream of P53 in this pathway.","method":"Chromatin immunoprecipitation (ChIP), luciferase reporter assay, P53 knockdown epistasis, RT-qPCR and western blot","journal":"OncoTargets and therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and luciferase assay establish direct promoter binding, epistasis places FOXN4 upstream of P53, single lab","pmids":["32021256"],"is_preprint":false},{"year":2023,"finding":"FOXN4 enhances its binding to HIF-1α and upregulates MMP2 expression, mediating ferroptosis to regulate cardiomyocyte functional activity in myocardial ischemia-reperfusion injury. Knockdown of FOXN4 alleviated oxidative stress, inhibited ROS production, and inhibited ferroptosis in MIR-injured cardiomyocytes.","method":"Western blot for signaling proteins, FOXN4/HIF-1α binding assay, knockdown in cardiomyocytes/rat MIRI model, ROS/ferroptosis marker measurement","journal":"Cellular and molecular biology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — binding between FOXN4 and HIF-1α reported but method detail limited in abstract; single lab, limited mechanistic validation","pmids":["37605566"],"is_preprint":false},{"year":2024,"finding":"A short hydrophobic motif (LXXLXWL) shared by Foxn4 (and Foxj1, Foxn3) is required for association with the Rfx3 protein and for full transcriptional activation by Foxn4 with Rfx3. Mutations in Rfx3 at the predicted interaction site disrupted Rfx3 association with Foxn4.","method":"CUTCRUN, AlphaFold3 structural prediction, mutagenesis of Foxn4 hydrophobic motif and Rfx3 interaction site, co-association assay","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis with functional transcriptional assay and structural prediction, preprint not yet peer-reviewed","pmids":["bio_10.1101_2024.10.28.620684"],"is_preprint":true}],"current_model":"FOXN4 is a forkhead/winged-helix transcription factor that acts as a temporal identity factor and cell fate regulator in multiple developmental contexts: in the retina it confers mid/late-early progenitor competence by directly activating Dll4-Notch signaling (via conserved enhancers) to suppress photoreceptor fates and promote amacrine/horizontal cell genesis through downstream targets Math3, NeuroD1, and Prox1; in the spinal cord it directly binds the Dll4 enhancer together with Ascl1 to asymmetrically activate Notch signaling, which in turn triggers BMP/TGFβ-mediated V2b interneuron fate specification; in the zebrafish heart it directly binds conserved tbx2 enhancer elements to regulate tbx2b expression and AV canal formation; it contains a C-terminal activation domain (aa 402–455) required for transcriptional activity; and it associates with Rfx3 via a conserved LXXLXWL motif to regulate target gene expression."},"narrative":{"mechanistic_narrative":"FOXN4 is a forkhead/winged-helix transcription factor that acts as a temporal identity and cell-fate regulator across multiple developmental contexts, controlling progenitor competence by activating Notch signaling and defined downstream transcriptional cascades [PMID:15363391, PMID:22323600, PMID:32071204]. In the retina, Foxn4 is necessary and sufficient for amacrine cell commitment and nonredundantly required for horizontal cell genesis, acting through the retinogenic factors Math3, NeuroD1, and Prox1 [PMID:15363391]; it functions as a temporal transcription factor that confers mid/late-early progenitor competence while suppressing the immediate-early retinal ganglion cell fate, positively regulating the downstream factor Casz1 and negatively regulating the upstream factor Ikzf1 [PMID:32071204]. A central mechanism is direct, enhancer-mediated activation of the Notch ligand Dll4: Foxn4 binds phylogenetically conserved Dll4 enhancers to expand the progenitor pool and suppress photoreceptor fates in the retina [PMID:22323600], and in the spinal cord it cooperates with the proneural bHLH factor Ascl1/Mash1 to asymmetrically activate Dll4 at the same enhancer, driving Notch1 signaling and downstream BMP/TGFβ activation that specifies V2b interneuron identity over the V2a alternative [PMID:16020526, PMID:17728344, PMID:24257627]. In the zebrafish heart, Foxn4 directly binds a conserved tbx2 enhancer to regulate tbx2b expression during atrioventricular canal formation [PMID:18347092]. Transcriptional activity requires a C-terminal activation domain (aa 402–455) [PMID:21701787], and Foxn4 associates with Rfx3 through a conserved LXXLXWL hydrophobic motif to achieve full target-gene activation [PMID:bio_10.1101_2024.10.28.620684]. Its own expression is driven by Meis1 acting at a conserved upstream cis-element [PMID:24244849]. FOXN4 can substitute for FOXN1 to confer thymopoietic activity, with the resulting bipotent lymphoid organ reflecting an IL7/DLL4 imbalance [PMID:25131198].","teleology":[{"year":2004,"claim":"Established FOXN4 as a determinant of retinal neuron fate by showing it is both necessary and sufficient for amacrine and horizontal cell genesis, answering whether a single forkhead factor controls these lineages.","evidence":"Targeted knockout and overexpression in mouse retinal progenitors with analysis of downstream retinogenic factors","pmids":["15363391"],"confidence":"High","gaps":["Did not establish whether downstream targets Math3/NeuroD1/Prox1 are direct transcriptional targets","No enhancer or DNA-binding mechanism defined at this stage"]},{"year":2005,"claim":"Extended FOXN4 function beyond the retina by showing it cooperates with Mash1 to specify V2b interneuron identity, resolving how a binary p2 progenitor fate choice is controlled.","evidence":"Foxn4 loss-of-function, overexpression, and double-mutant epistasis with Mash1 in spinal neural progenitors","pmids":["16020526"],"confidence":"High","gaps":["Molecular intermediary linking Foxn4/Mash1 to fate switch not yet identified","Direct targets not defined"]},{"year":2007,"claim":"Identified Dll4-Notch as the effector pathway, showing Foxn4 induces Dll4 and Mash1 to subdivide the p2 pool via Notch1, mechanistically connecting the transcription factor to lateral signaling.","evidence":"Mouse and chick loss- and gain-of-function with epistasis analysis","pmids":["17728344"],"confidence":"High","gaps":["Did not demonstrate direct Foxn4 binding to the Dll4 enhancer","Downstream signaling from Notch not yet resolved"]},{"year":2008,"claim":"Demonstrated direct enhancer binding in a new organ context, showing zebrafish Foxn4 binds a conserved tbx2 enhancer to control tbx2b and atrioventricular canal formation, establishing direct cis-regulatory activity.","evidence":"Zebrafish genetic analysis and enhancer-binding assay with functionally validated conserved Foxn4/T-box sites","pmids":["18347092"],"confidence":"High","gaps":["Cooperating T-box factor at the enhancer not identified","Generalizability of direct binding to other targets not yet shown"]},{"year":2012,"claim":"Established the direct mechanistic link between Foxn4 and Notch in the retina, showing it activates Dll4 via conserved enhancers to expand progenitors and suppress photoreceptor fates.","evidence":"Bioinformatic, conditional genetic, and biochemical enhancer-activation approaches in mouse retina","pmids":["22323600"],"confidence":"High","gaps":["Cofactors at the retinal Dll4 enhancer not defined","Quantitative contribution of Dll4 vs other ligands not fully partitioned"]},{"year":2013,"claim":"Unified the spinal cord mechanism by showing Foxn4 and Ascl1 directly co-bind the Dll4 enhancer for asymmetric activation, with BMP/TGFβ acting downstream as the necessary and sufficient V2b determinant.","evidence":"Direct enhancer-binding assays, Cre-LoxP lineage tracing, gain-of-function, and BMP/TGFβ pathway inhibition by antagonists and RNAi","pmids":["24257627"],"confidence":"High","gaps":["How Neurog proteins block Foxn4/Ascl1 activation mechanistically not resolved","Direct BMP/TGFβ target genes downstream not identified"]},{"year":2011,"claim":"Mapped the transcriptional activation determinant, showing the aa 402–455 region is required for Foxn4 activity, defining the functional module needed for target regulation.","evidence":"Domain deletion mutagenesis with in vitro promoter assays and retinal explant gain-of-function","pmids":["21701787"],"confidence":"Medium","gaps":["Cofactors recruited by this activation domain not identified","Structural basis of activation not determined"]},{"year":2011,"claim":"Revealed an upstream regulatory input by showing Meis1 drives Foxn4 expression through a conserved upstream cis-element, addressing how Foxn4 itself is temporally controlled.","evidence":"Reporter assays, Meis1 binding-motif deletion, and Meis1 knockdown with endogenous expression analysis","pmids":["24244849"],"confidence":"Medium","gaps":["Whether Meis1 binding is direct in vivo at the endogenous locus not shown","Other inputs to the CR4.2 element not characterized"]},{"year":2011,"claim":"Expanded FOXN4 roles to non-neural tissues, implicating it in alveologenesis and in non-cell-autonomous control of RGC axon patterning via its amacrine cell function.","evidence":"Targeted inactivation with histology, PDGFA/SFTPB expression analysis (lung), and axon tracing/retinal wave recording (RGC)","pmids":["21438071","21334440"],"confidence":"Medium","gaps":["Direct molecular mediator of non-cell-autonomy not established in either tissue","Single-lab findings without independent replication"]},{"year":2014,"claim":"Used a FOXN1-replacement strategy to show FOXN4 has intrinsic thymopoietic activity but yields a bipotent lymphoid organ, illuminating the IL7/DLL4 balance underlying T-cell-exclusive thymus evolution.","evidence":"Knock-in replacement of FOXN1 with FOXN4 in mice with functional lymphocyte and cytokine/ligand analysis","pmids":["25131198"],"confidence":"High","gaps":["Direct FOXN4 target genes in thymic epithelium not mapped","Mechanism setting IL7 vs DLL4 output not fully resolved"]},{"year":2020,"claim":"Formalized Foxn4 as a temporal transcription factor within a tTF cascade, showing it confers mid/late-early competence and regulates Casz1 and Ikzf1, integrating its many fate roles into a temporal-identity framework.","evidence":"Temporal cluster analysis, RNA-seq, retina-specific loss- and gain-of-function, and tTF cascade epistasis","pmids":["32071204"],"confidence":"High","gaps":["Whether Casz1/Ikzf1 regulation is via direct binding not established","Mechanism of synaptogenesis/maintenance defects not resolved"]},{"year":2020,"claim":"Identified a disease-context circuit by showing FOXN4 directly binds and activates the TP53 promoter to suppress breast cancer growth, placing FOXN4 upstream of p53.","evidence":"ChIP, luciferase reporter assays, and P53-knockdown epistasis in breast cancer cells","pmids":["32021256"],"confidence":"Medium","gaps":["Reconciliation with reported direct FOXN4–TP53 protein interaction unclear","Relevance of TP53 regulation to developmental FOXN4 function not addressed"]},{"year":2024,"claim":"Defined a cofactor-recruitment mechanism, identifying a conserved LXXLXWL motif required for Foxn4 association with Rfx3 and full transcriptional activation.","evidence":"CUT&RUN, AlphaFold3 prediction, and reciprocal mutagenesis of the Foxn4 motif and Rfx3 interaction site (preprint)","pmids":["bio_10.1101_2024.10.28.620684"],"confidence":"Medium","gaps":["Preprint not yet peer-reviewed","Shared target genes regulated by the Foxn4–Rfx3 complex not defined","Generality of motif use across Foxn4 contexts unknown"]},{"year":null,"claim":"It remains unknown how FOXN4 selects context-specific enhancers and partner factors (Ascl1, T-box factors, Rfx3) to deploy distinct fate programs across retina, spinal cord, heart, and thymus from a shared DNA-binding activity.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No genome-wide direct target map integrating multiple tissues","Structural basis of partner selectivity unresolved","Direct vs indirect status of many downstream targets undetermined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,4,8,11]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[3,4,5,13]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[8,13]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,2,4,5,11]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[4,5,8,13]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,4,5]}],"complexes":[],"partners":["ASCL1","RFX3","TP53","HIF1A","MEIS1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96NZ1","full_name":"Forkhead box protein N4","aliases":[],"length_aa":517,"mass_kda":55.2,"function":"Transcription factor essential for neural and some non-neural tissues development, such as retina and lung respectively. Binds to an 11-bp consensus sequence containing the invariant tetranucleotide 5'-ACGC-3'. During development of the central nervous system, is required to specify the amacrine and horizontal cell fates from multipotent retinal progenitors while suppressing the alternative photoreceptor cell fates through activating DLL4-NOTCH signaling. Also acts synergistically with ASCL1/MASH1 to activate DLL4-NOTCH signaling and drive commitment of p2 progenitors to the V2b interneuron fates during spinal cord neurogenesis. In development of non-neural tissues, plays an essential role in the specification of the atrioventricular canal and is indirectly required for patterning the distal airway during lung development (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q96NZ1/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FOXN4","classification":"Not Classified","n_dependent_lines":51,"n_total_lines":1208,"dependency_fraction":0.042218543046357616},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FOXN4","total_profiled":1310},"omim":[{"mim_id":"609429","title":"FORKHEAD BOX N4; FOXN4","url":"https://www.omim.org/entry/609429"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Mitochondria","reliability":"Approved"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"testis","ntpm":10.9}],"url":"https://www.proteinatlas.org/search/FOXN4"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q96NZ1","domains":[{"cath_id":"1.10.10.10","chopping":"199-313","consensus_level":"high","plddt":90.9179,"start":199,"end":313}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96NZ1","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96NZ1-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96NZ1-F1-predicted_aligned_error_v6.png","plddt_mean":57.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FOXN4","jax_strain_url":"https://www.jax.org/strain/search?query=FOXN4"},"sequence":{"accession":"Q96NZ1","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96NZ1.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96NZ1/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96NZ1"}},"corpus_meta":[{"pmid":"18347092","id":"PMC_18347092","title":"Foxn4 directly regulates tbx2b expression and atrioventricular canal formation.","date":"2008","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/18347092","citation_count":336,"is_preprint":false},{"pmid":"15363391","id":"PMC_15363391","title":"Foxn4 controls the genesis of amacrine and horizontal cells by retinal progenitors.","date":"2004","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/15363391","citation_count":204,"is_preprint":false},{"pmid":"17728344","id":"PMC_17728344","title":"A regulatory network involving Foxn4, Mash1 and delta-like 4/Notch1 generates V2a and V2b spinal interneurons from a common progenitor pool.","date":"2007","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17728344","citation_count":96,"is_preprint":false},{"pmid":"16020526","id":"PMC_16020526","title":"Foxn4 acts synergistically with Mash1 to specify subtype identity of V2 interneurons in the spinal cord.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16020526","citation_count":79,"is_preprint":false},{"pmid":"22323600","id":"PMC_22323600","title":"Forkhead box N4 (Foxn4) activates Dll4-Notch signaling to suppress photoreceptor cell fates of early retinal progenitors.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22323600","citation_count":65,"is_preprint":false},{"pmid":"32071204","id":"PMC_32071204","title":"Foxn4 is a temporal identity factor conferring mid/late-early retinal competence and involved in retinal synaptogenesis.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32071204","citation_count":40,"is_preprint":false},{"pmid":"11520680","id":"PMC_11520680","title":"Foxn4--a new member of the forkhead gene family is expressed in the retina.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11520680","citation_count":35,"is_preprint":false},{"pmid":"24257627","id":"PMC_24257627","title":"Asymmetric activation of Dll4-Notch signaling by Foxn4 and proneural factors activates BMP/TGFβ signaling to specify V2b interneurons in the spinal cord.","date":"2013","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24257627","citation_count":33,"is_preprint":false},{"pmid":"25131198","id":"PMC_25131198","title":"Conversion of the thymus into a bipotent lymphoid organ by replacement of FOXN1 with its paralog, FOXN4.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25131198","citation_count":33,"is_preprint":false},{"pmid":"18006384","id":"PMC_18006384","title":"Temporal and spatial expression of transcription factors FoxN4, Ptf1a, Prox1, Isl1 and Lim1 mRNA in the developing chick retina.","date":"2007","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/18006384","citation_count":26,"is_preprint":false},{"pmid":"15464224","id":"PMC_15464224","title":"Expression of the winged helix/forkhead gene, foxn4, during zebrafish development.","date":"2004","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/15464224","citation_count":16,"is_preprint":false},{"pmid":"24244849","id":"PMC_24244849","title":"Meis1 regulates Foxn4 expression during retinal progenitor cell differentiation.","date":"2013","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/24244849","citation_count":15,"is_preprint":false},{"pmid":"23314287","id":"PMC_23314287","title":"Forkheadbox N4 (FoxN4) triggers context-dependent differentiation in the developing chick retina and neural tube.","date":"2013","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/23314287","citation_count":15,"is_preprint":false},{"pmid":"24008385","id":"PMC_24008385","title":"Foxn4: a multi-faceted transcriptional regulator of cell fates in vertebrate development.","date":"2013","source":"Science China. Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24008385","citation_count":13,"is_preprint":false},{"pmid":"21438071","id":"PMC_21438071","title":"Foxn4 influences alveologenesis during lung development.","date":"2011","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/21438071","citation_count":11,"is_preprint":false},{"pmid":"17110173","id":"PMC_17110173","title":"Expression of the forkhead transcription factor FoxN4 in progenitor cells in the developing Xenopus laevis retina and brain.","date":"2006","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/17110173","citation_count":10,"is_preprint":false},{"pmid":"40352924","id":"PMC_40352924","title":"The miR-941/FOXN4/TGF-β feedback loop induces N2 polarization of neutrophils and enhances tumor progression of lung adenocarcinoma.","date":"2025","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/40352924","citation_count":9,"is_preprint":false},{"pmid":"37605566","id":"PMC_37605566","title":"FOXN4 affects myocardial ischemia-reperfusion injury through HIF-1α/MMP2-mediated ferroptosis of cardiomyocytes.","date":"2023","source":"Cellular and molecular biology (Noisy-le-Grand, France)","url":"https://pubmed.ncbi.nlm.nih.gov/37605566","citation_count":5,"is_preprint":false},{"pmid":"21334440","id":"PMC_21334440","title":"Foxn4 is required for retinal ganglion cell distal axon patterning.","date":"2011","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/21334440","citation_count":5,"is_preprint":false},{"pmid":"21701787","id":"PMC_21701787","title":"A regulatory domain is required for Foxn4 activity during retinogenesis.","date":"2011","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/21701787","citation_count":4,"is_preprint":false},{"pmid":"31430519","id":"PMC_31430519","title":"Identification of FOXN4 as a tumor suppressor of breast carcinogenesis via the activation of TP53 and deactivation of Notch signaling.","date":"2019","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/31430519","citation_count":4,"is_preprint":false},{"pmid":"15492871","id":"PMC_15492871","title":"Characterization of human FOXN4 gene in silico.","date":"2004","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15492871","citation_count":3,"is_preprint":false},{"pmid":"24217796","id":"PMC_24217796","title":"Up-regulation of FoxN4 expression in adult spinal cord after injury.","date":"2013","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/24217796","citation_count":3,"is_preprint":false},{"pmid":"32021256","id":"PMC_32021256","title":"FOXN4 Inhibits Breast Cancer Progression By Direct Activation Of P53.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32021256","citation_count":1,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.10.28.620684","title":"<i>Foxn3</i>  is part of a transcriptional network that regulates primary cilia in the developing retina","date":"2024-10-28","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.28.620684","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":12677,"output_tokens":4182,"usd":0.050381,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":12080,"output_tokens":4350,"usd":0.084575,"stage2_stop_reason":"end_turn"},"total_usd":0.134956,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"Foxn4 is necessary and sufficient for commitment to the amacrine cell fate and is nonredundantly required for the genesis of horizontal cells in mouse retina. Targeted disruption largely eliminates amacrine neurons and completely abolishes horizontal cells, while overexpression strongly promotes amacrine cell fate. Foxn4 controls these fates by activating expression of retinogenic factors Math3, NeuroD1, and Prox1.\",\n      \"method\": \"Targeted gene disruption (knockout), overexpression in retinal progenitors, expression analysis of downstream targets\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function and gain-of-function with defined cellular phenotypes and downstream target activation, replicated across multiple studies\",\n      \"pmids\": [\"15363391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Foxn4 cooperates with bHLH factor Mash1 to specify V2b interneuron identity from bipotential p2 progenitors in the spinal cord. Loss of Foxn4 eliminates Mash1 expression and V2b neurons with a fate-switch to V2a neurons. Overexpression of Foxn4 alone promotes V2a fate, but coexpression of Foxn4 and Mash1 together promotes the V2b fate while inhibiting V2a fate.\",\n      \"method\": \"Loss-of-function (Foxn4 knockout), overexpression in spinal neural progenitors, genetic epistasis with Mash1 knockout\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic manipulations (KO, OE, double mutant) with defined cellular phenotypes and pathway placement\",\n      \"pmids\": [\"16020526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Foxn4 induces expression of Dll4 and Mash1 in p2 progenitors of the ventral spinal cord. Dll4 then signals through Notch1 to subdivide the p2 progenitor pool into V2a and V2b interneurons. Foxn4, Mash1, and activated Notch1 trigger the genetic cascade leading to V2b INs, while progenitors without active Notch1 generate V2a INs.\",\n      \"method\": \"Mouse and chick genetic experiments, loss-of-function and gain-of-function, epistasis analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — replicated in two model organisms with multiple genetic manipulations and pathway placement\",\n      \"pmids\": [\"17728344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Zebrafish Foxn4 (encoded by slipjig) regulates atrioventricular canal formation by directly binding to a highly conserved tbx2 enhancer domain containing Foxn4- and T-box-binding sites, thereby regulating tbx2b expression in the AV canal.\",\n      \"method\": \"Genetic analysis in zebrafish, enhancer binding assay, identification of conserved Foxn4-binding sites in tbx2 enhancer\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct binding to enhancer demonstrated, zebrafish loss-of-function with specific cardiac phenotype, conserved binding sites functionally validated\",\n      \"pmids\": [\"18347092\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Foxn4 suppresses photoreceptor cell fates of early retinal progenitors by selectively activating Dll4-Notch signaling. Dll4 is directly activated by Foxn4 via phylogenetically conserved enhancers, and Dll4 mediates Foxn4 function by serving as a major Notch ligand to expand the progenitor pool and limit photoreceptor production.\",\n      \"method\": \"Bioinformatic, genetic, and biochemical approaches; conditional ablation; gene expression analysis; direct enhancer activation assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct enhancer activation, conditional genetics, multiple orthogonal methods in one study\",\n      \"pmids\": [\"22323600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Foxn4 and Ascl1 (proneural bHLH factor) directly bind to a conserved Dll4 enhancer to activate Dll4 expression in V2 precursors, whereas Neurog proteins prevent this effect, resulting in asymmetric Dll4 activation. BMP/TGFβ signaling is activated in V2b precursors downstream of Dll4-Notch signaling, and this BMP/TGFβ signaling is necessary and sufficient for V2b fate specification.\",\n      \"method\": \"Direct enhancer binding assay, Cre-LoxP lineage tracing, gain-of-function, BMP/TGFβ pathway inhibition with antagonists and RNAi knockdown\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct enhancer binding demonstrated, multiple epistasis experiments, pathway inhibition with multiple methods\",\n      \"pmids\": [\"24257627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Foxn4 is expressed in proximal airway epithelial cells during lung development. Targeted inactivation of Foxn4 causes dilated alveoli, thinned alveolar walls, and reduced septa in the distal lung, associated with decreased PDGFA signaling and reduced surfactant protein B (SFTPB) expression, suggesting a non-cell-autonomous role in alveologenesis.\",\n      \"method\": \"Targeted gene inactivation, histology, expression analysis of PDGFA and SFTPB\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO with defined phenotype and downstream pathway changes, single lab, no direct molecular mechanism for non-cell-autonomy established\",\n      \"pmids\": [\"21438071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Foxn4 deletion reduces amacrine cell number without affecting RGC number, and Foxn4-null mice show a developmental delay in RGC projections to the superior colliculus and failure of RGC axons to penetrate retinorecipient layers. Foxn4 is not expressed by RGCs or in the superior colliculus, indicating this is an indirect (amacrine cell-mediated) effect on RGC axon patterning.\",\n      \"method\": \"Foxn4 knockout mouse analysis, immunohistochemistry for amacrine subtypes, retinal wave recording, axonal projection tracing\",\n      \"journal\": \"Molecular and cellular neurosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — KO with defined cellular phenotype and non-cell-autonomous mechanism inferred, single lab, indirect mechanism not directly tested\",\n      \"pmids\": [\"21334440\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The region between amino acids 402 and 455 of Foxn4 protein (homologous to the activation domain of Foxn1) is required for Foxn4 transcriptional activity both in vitro (target promoter transcription assay) and in retina (regulation of target retinogenic factors). Deletion of this putative activation domain completely abolishes Foxn4 activity during retinogenesis.\",\n      \"method\": \"Domain deletion mutagenesis, gain-of-function in rat and chick retinal explants, target promoter transcription assay\",\n      \"journal\": \"Journal of molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mutagenesis with in vitro and in vivo functional validation, single lab\",\n      \"pmids\": [\"21701787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Meis1 transcription factor regulates Foxn4 expression during retinal progenitor differentiation by binding to a Meis1 binding motif within a conserved 129 bp cis-regulatory element (CR4.2) located ~26 kb upstream of the Foxn4 transcription start site. Knockdown of Meis1 abolishes CR4.2 regulatory activity and diminishes endogenous Foxn4 expression.\",\n      \"method\": \"Reporter assay with conserved cis-element, Meis1 binding motif deletion, Meis1 knockdown, expression analysis\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — binding motif deletion and knockdown with reporter and endogenous expression validation, single lab\",\n      \"pmids\": [\"24244849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"FOXN4 exhibits substantial thymopoietic activity when substituted for FOXN1 in thymic epithelial cells of mice. The FOXN4-replaced thymus generates both T and B cells (bipotent lymphoid organ), linked to a functional imbalance between lymphopoietic cytokine IL7 and T cell specification factor DLL4, identifying the evolutionary mechanism underlying conversion of a general lymphopoietic organ to exclusive T cell generation.\",\n      \"method\": \"Knock-in replacement of FOXN1 with FOXN4 in mice, histological analysis, functional lymphocyte analysis, cytokine/ligand expression analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct in vivo replacement experiment with rigorous functional readouts, mechanistic pathway (IL7/DLL4 imbalance) identified\",\n      \"pmids\": [\"25131198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Foxn4 functions as a temporal transcription factor (tTF) during retinogenesis, conferring retinal progenitor cells (RPCs) with competence to generate mid/late-early cell types (amacrine, horizontal, cone, rod cells) while suppressing generation of the immediate-early cell type (retinal ganglion cells). Foxn4 positively regulates its downstream tTF Casz1 while negatively regulating its upstream tTF Ikzf1. Retina-specific Foxn4 ablation also affects synaptogenesis and long-term retinal maintenance.\",\n      \"method\": \"Temporal cluster analysis, RNA-sequencing, retina-specific loss-of-function and gain-of-function, analysis of upstream/downstream tTF cascade\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal approaches (transcriptomics, KO, OE, epistasis within tTF cascade) in single study\",\n      \"pmids\": [\"32071204\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"FOXN4 directly interacts with TP53 (p53 protein) in breast cancer cells, and this interaction leads to increased TP53 activity. Silencing FOXN4 reduces TP53 and increases expression of Dll4, Notch, and survivin.\",\n      \"method\": \"Co-immunoprecipitation (direct interaction with TP53), overexpression and knockdown in breast cancer cell lines, western blot\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP for interaction claim, single lab, limited mechanistic follow-up\",\n      \"pmids\": [\"31430519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"FOXN4 directly binds to the promoter of TP53 (P53) and activates P53 expression. Knockdown of P53 rescues the tumor-inhibitory effects of FOXN4 in breast cancer cells, placing FOXN4 upstream of P53 in this pathway.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), luciferase reporter assay, P53 knockdown epistasis, RT-qPCR and western blot\",\n      \"journal\": \"OncoTargets and therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and luciferase assay establish direct promoter binding, epistasis places FOXN4 upstream of P53, single lab\",\n      \"pmids\": [\"32021256\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"FOXN4 enhances its binding to HIF-1α and upregulates MMP2 expression, mediating ferroptosis to regulate cardiomyocyte functional activity in myocardial ischemia-reperfusion injury. Knockdown of FOXN4 alleviated oxidative stress, inhibited ROS production, and inhibited ferroptosis in MIR-injured cardiomyocytes.\",\n      \"method\": \"Western blot for signaling proteins, FOXN4/HIF-1α binding assay, knockdown in cardiomyocytes/rat MIRI model, ROS/ferroptosis marker measurement\",\n      \"journal\": \"Cellular and molecular biology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — binding between FOXN4 and HIF-1α reported but method detail limited in abstract; single lab, limited mechanistic validation\",\n      \"pmids\": [\"37605566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"A short hydrophobic motif (LXXLXWL) shared by Foxn4 (and Foxj1, Foxn3) is required for association with the Rfx3 protein and for full transcriptional activation by Foxn4 with Rfx3. Mutations in Rfx3 at the predicted interaction site disrupted Rfx3 association with Foxn4.\",\n      \"method\": \"CUTCRUN, AlphaFold3 structural prediction, mutagenesis of Foxn4 hydrophobic motif and Rfx3 interaction site, co-association assay\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis with functional transcriptional assay and structural prediction, preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2024.10.28.620684\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"FOXN4 is a forkhead/winged-helix transcription factor that acts as a temporal identity factor and cell fate regulator in multiple developmental contexts: in the retina it confers mid/late-early progenitor competence by directly activating Dll4-Notch signaling (via conserved enhancers) to suppress photoreceptor fates and promote amacrine/horizontal cell genesis through downstream targets Math3, NeuroD1, and Prox1; in the spinal cord it directly binds the Dll4 enhancer together with Ascl1 to asymmetrically activate Notch signaling, which in turn triggers BMP/TGFβ-mediated V2b interneuron fate specification; in the zebrafish heart it directly binds conserved tbx2 enhancer elements to regulate tbx2b expression and AV canal formation; it contains a C-terminal activation domain (aa 402–455) required for transcriptional activity; and it associates with Rfx3 via a conserved LXXLXWL motif to regulate target gene expression.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"FOXN4 is a forkhead/winged-helix transcription factor that acts as a temporal identity and cell-fate regulator across multiple developmental contexts, controlling progenitor competence by activating Notch signaling and defined downstream transcriptional cascades [#0, #4, #11]. In the retina, Foxn4 is necessary and sufficient for amacrine cell commitment and nonredundantly required for horizontal cell genesis, acting through the retinogenic factors Math3, NeuroD1, and Prox1 [#0]; it functions as a temporal transcription factor that confers mid/late-early progenitor competence while suppressing the immediate-early retinal ganglion cell fate, positively regulating the downstream factor Casz1 and negatively regulating the upstream factor Ikzf1 [#11]. A central mechanism is direct, enhancer-mediated activation of the Notch ligand Dll4: Foxn4 binds phylogenetically conserved Dll4 enhancers to expand the progenitor pool and suppress photoreceptor fates in the retina [#4], and in the spinal cord it cooperates with the proneural bHLH factor Ascl1/Mash1 to asymmetrically activate Dll4 at the same enhancer, driving Notch1 signaling and downstream BMP/TGFβ activation that specifies V2b interneuron identity over the V2a alternative [#1, #2, #5]. In the zebrafish heart, Foxn4 directly binds a conserved tbx2 enhancer to regulate tbx2b expression during atrioventricular canal formation [#3]. Transcriptional activity requires a C-terminal activation domain (aa 402\\u2013455) [#8], and Foxn4 associates with Rfx3 through a conserved LXXLXWL hydrophobic motif to achieve full target-gene activation [#15]. Its own expression is driven by Meis1 acting at a conserved upstream cis-element [#9]. FOXN4 can substitute for FOXN1 to confer thymopoietic activity, with the resulting bipotent lymphoid organ reflecting an IL7/DLL4 imbalance [#10].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Established FOXN4 as a determinant of retinal neuron fate by showing it is both necessary and sufficient for amacrine and horizontal cell genesis, answering whether a single forkhead factor controls these lineages.\",\n      \"evidence\": \"Targeted knockout and overexpression in mouse retinal progenitors with analysis of downstream retinogenic factors\",\n      \"pmids\": [\"15363391\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish whether downstream targets Math3/NeuroD1/Prox1 are direct transcriptional targets\", \"No enhancer or DNA-binding mechanism defined at this stage\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Extended FOXN4 function beyond the retina by showing it cooperates with Mash1 to specify V2b interneuron identity, resolving how a binary p2 progenitor fate choice is controlled.\",\n      \"evidence\": \"Foxn4 loss-of-function, overexpression, and double-mutant epistasis with Mash1 in spinal neural progenitors\",\n      \"pmids\": [\"16020526\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular intermediary linking Foxn4/Mash1 to fate switch not yet identified\", \"Direct targets not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identified Dll4-Notch as the effector pathway, showing Foxn4 induces Dll4 and Mash1 to subdivide the p2 pool via Notch1, mechanistically connecting the transcription factor to lateral signaling.\",\n      \"evidence\": \"Mouse and chick loss- and gain-of-function with epistasis analysis\",\n      \"pmids\": [\"17728344\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not demonstrate direct Foxn4 binding to the Dll4 enhancer\", \"Downstream signaling from Notch not yet resolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrated direct enhancer binding in a new organ context, showing zebrafish Foxn4 binds a conserved tbx2 enhancer to control tbx2b and atrioventricular canal formation, establishing direct cis-regulatory activity.\",\n      \"evidence\": \"Zebrafish genetic analysis and enhancer-binding assay with functionally validated conserved Foxn4/T-box sites\",\n      \"pmids\": [\"18347092\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cooperating T-box factor at the enhancer not identified\", \"Generalizability of direct binding to other targets not yet shown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Established the direct mechanistic link between Foxn4 and Notch in the retina, showing it activates Dll4 via conserved enhancers to expand progenitors and suppress photoreceptor fates.\",\n      \"evidence\": \"Bioinformatic, conditional genetic, and biochemical enhancer-activation approaches in mouse retina\",\n      \"pmids\": [\"22323600\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cofactors at the retinal Dll4 enhancer not defined\", \"Quantitative contribution of Dll4 vs other ligands not fully partitioned\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Unified the spinal cord mechanism by showing Foxn4 and Ascl1 directly co-bind the Dll4 enhancer for asymmetric activation, with BMP/TGFβ acting downstream as the necessary and sufficient V2b determinant.\",\n      \"evidence\": \"Direct enhancer-binding assays, Cre-LoxP lineage tracing, gain-of-function, and BMP/TGFβ pathway inhibition by antagonists and RNAi\",\n      \"pmids\": [\"24257627\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Neurog proteins block Foxn4/Ascl1 activation mechanistically not resolved\", \"Direct BMP/TGFβ target genes downstream not identified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Mapped the transcriptional activation determinant, showing the aa 402\\u2013455 region is required for Foxn4 activity, defining the functional module needed for target regulation.\",\n      \"evidence\": \"Domain deletion mutagenesis with in vitro promoter assays and retinal explant gain-of-function\",\n      \"pmids\": [\"21701787\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cofactors recruited by this activation domain not identified\", \"Structural basis of activation not determined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Revealed an upstream regulatory input by showing Meis1 drives Foxn4 expression through a conserved upstream cis-element, addressing how Foxn4 itself is temporally controlled.\",\n      \"evidence\": \"Reporter assays, Meis1 binding-motif deletion, and Meis1 knockdown with endogenous expression analysis\",\n      \"pmids\": [\"24244849\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Meis1 binding is direct in vivo at the endogenous locus not shown\", \"Other inputs to the CR4.2 element not characterized\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Expanded FOXN4 roles to non-neural tissues, implicating it in alveologenesis and in non-cell-autonomous control of RGC axon patterning via its amacrine cell function.\",\n      \"evidence\": \"Targeted inactivation with histology, PDGFA/SFTPB expression analysis (lung), and axon tracing/retinal wave recording (RGC)\",\n      \"pmids\": [\"21438071\", \"21334440\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular mediator of non-cell-autonomy not established in either tissue\", \"Single-lab findings without independent replication\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Used a FOXN1-replacement strategy to show FOXN4 has intrinsic thymopoietic activity but yields a bipotent lymphoid organ, illuminating the IL7/DLL4 balance underlying T-cell-exclusive thymus evolution.\",\n      \"evidence\": \"Knock-in replacement of FOXN1 with FOXN4 in mice with functional lymphocyte and cytokine/ligand analysis\",\n      \"pmids\": [\"25131198\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct FOXN4 target genes in thymic epithelium not mapped\", \"Mechanism setting IL7 vs DLL4 output not fully resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Formalized Foxn4 as a temporal transcription factor within a tTF cascade, showing it confers mid/late-early competence and regulates Casz1 and Ikzf1, integrating its many fate roles into a temporal-identity framework.\",\n      \"evidence\": \"Temporal cluster analysis, RNA-seq, retina-specific loss- and gain-of-function, and tTF cascade epistasis\",\n      \"pmids\": [\"32071204\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Casz1/Ikzf1 regulation is via direct binding not established\", \"Mechanism of synaptogenesis/maintenance defects not resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified a disease-context circuit by showing FOXN4 directly binds and activates the TP53 promoter to suppress breast cancer growth, placing FOXN4 upstream of p53.\",\n      \"evidence\": \"ChIP, luciferase reporter assays, and P53-knockdown epistasis in breast cancer cells\",\n      \"pmids\": [\"32021256\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reconciliation with reported direct FOXN4\\u2013TP53 protein interaction unclear\", \"Relevance of TP53 regulation to developmental FOXN4 function not addressed\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined a cofactor-recruitment mechanism, identifying a conserved LXXLXWL motif required for Foxn4 association with Rfx3 and full transcriptional activation.\",\n      \"evidence\": \"CUT&RUN, AlphaFold3 prediction, and reciprocal mutagenesis of the Foxn4 motif and Rfx3 interaction site (preprint)\",\n      \"pmids\": [\"bio_10.1101_2024.10.28.620684\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint not yet peer-reviewed\", \"Shared target genes regulated by the Foxn4\\u2013Rfx3 complex not defined\", \"Generality of motif use across Foxn4 contexts unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how FOXN4 selects context-specific enhancers and partner factors (Ascl1, T-box factors, Rfx3) to deploy distinct fate programs across retina, spinal cord, heart, and thymus from a shared DNA-binding activity.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No genome-wide direct target map integrating multiple tissues\", \"Structural basis of partner selectivity unresolved\", \"Direct vs indirect status of many downstream targets undetermined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 4, 8, 11]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [3, 4, 5, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [8, 13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 2, 4, 5, 11]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [4, 5, 8, 13]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 4, 5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ASCL1\", \"RFX3\", \"TP53\", \"HIF1A\", \"MEIS1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":7,"faith_pct":85.71428571428571}}